A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity

被引:7
|
作者
Schatz, Malvina [1 ]
Marty, Laetitia [1 ]
Ounadjela, Camille [1 ]
Tong, Phuoc Bao Viet [1 ]
Cardace, Ilaria [1 ]
Mettling, Clement [2 ]
Milhiet, Pierre-Emmanuel [3 ]
Costa, Luca [3 ]
Godefroy, Cedric [3 ]
Pugniere, Martine [4 ]
Guichou, Jean-Francois [3 ]
Mesnard, Jean-Michel [1 ]
Blaise, Mickael [1 ]
Beaumelle, Bruno [1 ]
机构
[1] Univ Montpellier, Inst Rech Infectiol Montpellier, UMR CNRS 9004, Montpellier, France
[2] Inst Genet Humaine, UPR CNRS 1142, Montpellier, France
[3] Univ Montpellier, Ctr Biol Struct, CNRS, INSERM, Montpellier, France
[4] Inst Rech Cancerol Montpellier, INSERM U 1194, Montpellier, France
关键词
capsid; HIV-1; Tat; cores; cyclophilin A; virions; IMMUNODEFICIENCY-VIRUS TYPE-1; CYCLOSPORINE-A; DEPENDENT STEPS; LIFE-CYCLE; TRANSCRIPTION; BINDING; ACETYLTRANSFERASE; TRANSACTIVATOR; REPLICATION; RESTRICTION;
D O I
10.1128/jvi.00278-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 Tat is a key viral protein that stimulates several steps of viral gene expression. Tat is especially required for the transcription of viral genes. Nevertheless, it is still not clear if and how Tat is incorporated into HIV-1 virions. Cyclophilin A (CypA) is a prolyl isomerase that binds to HIV-1 capsid protein (CA) and is thereby encapsidated at the level of 200 to 250 copies of CypA/virion. Here, we found that a Tat-CypA-CA tripartite complex assembles in HIV-1-infected cells and allows Tat encapsidation into HIV virions (1 Tat/1 CypA). Biochemical and biophysical studies showed that high-affinity interactions drive the assembly of the Tat-CypA-CA complex that could be purified by size exclusion chromatography. We prepared different types of viruses devoid of transcriptionally active Tat. They showed a 5- to 10 fold decrease in HIV infectivity, and conversely, encapsidating Tat into Delta Tat viruses greatly enhanced infectivity. The absence of encapsidated Tat decreased the efficiency of reverse transcription by similar to 50% and transcription by more than 90%. We thus identified a Tat-CypA-CA complex that enables Tat encapsidation and showed that encapsidated Tat is required to initiate robust viral transcription and thus viral production at the beginning of cell infection, before neosynthesized Tat becomes available.IMPORTANCE The viral transactivating protein Tat has been shown to stimulate several steps of HIV gene expression. It was found to facilitate reverse transcription. Moreover, Tat is strictly required for the transcription of viral genes. Although the presence of Tat within HIV virions would undoubtedly favor these steps and therefore enable the incoming virus to boost initial viral production, whether and how Tat is present within virions has been a matter a debate. We here described and characterized a tripartite complex between Tat, HIV capsid protein, and the cellular chaperone cyclophilin A that enables efficient and specific Tat encapsidation within HIV virions. We further showed that Tat encapsidation is required for the virus to efficiently initiate infection and viral production. This effect is mainly due to the transcriptional activity of Tat.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies
    Rice, Andrew P.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (28) : 4098 - 4102
  • [2] Genetic variation and function of the HIV-1 Tat protein
    Spector, Cassandra
    Mele, Anthony R.
    Wigdahl, Brian
    Nonnemacher, Michael R.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2019, 208 (02) : 131 - 169
  • [3] Tat is required for efficient HIV-1 reverse transcription
    Harrich, D
    Ulich, C
    GarciaMartinez, LF
    Gaynor, RB
    EMBO JOURNAL, 1997, 16 (06) : 1224 - 1235
  • [4] Genetic variation and function of the HIV-1 Tat protein
    Cassandra Spector
    Anthony R. Mele
    Brian Wigdahl
    Michael R. Nonnemacher
    Medical Microbiology and Immunology, 2019, 208 : 131 - 169
  • [5] A TRIPARTITE HIV-1 TAT-ENV-REV FUSION PROTEIN
    SALFELD, J
    GOTTLINGER, HG
    SIA, RA
    PARK, RE
    SODROSKI, JG
    HASELTINE, WA
    EMBO JOURNAL, 1990, 9 (03) : 965 - 970
  • [6] Molecular recognition in the HIV-1 capsid/cyclophilin a complex
    Yoo, SH
    Myszka, DG
    Yeh, CY
    McMurray, M
    Hill, CP
    Sundquist, WI
    JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (05) : 780 - 795
  • [7] Encapsidation of Staufen-2 Enhances Infectivity of HIV-1
    Balakrishnan, Kannan
    Jaguva Vasudevan, Ananda Ayyappan
    Mohareer, Krishnaveni
    Luedde, Tom
    Muenk, Carsten
    Banerjee, Sharmistha
    VIRUSES-BASEL, 2021, 13 (12):
  • [8] The Ins and Outs of HIV-1 Tat
    Debaisieux, Solene
    Rayne, Fabienne
    Yezid, Hocine
    Beaumelle, Bruno
    TRAFFIC, 2012, 13 (03) : 355 - 363
  • [9] Comparative analysis of HIV-1 Tat variants
    Pantano, S
    Carloni, P
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 58 (03) : 638 - 643
  • [10] Intrinsic Disorder and Function of the HIV-1 Tat Protein
    Shojania, Shaheen
    O'Neil, Joe D.
    PROTEIN AND PEPTIDE LETTERS, 2010, 17 (08) : 999 - 1011